Matthew T. Marin, Ozempic and GLP-1 lawsuit attorney at Marin & Murphy Law Firm

FIND OUT IF YOUR CASE QUALIFIESStomach injuries & NAION vision loss

Free confidential case review — no fee unless there is a recovery

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Calling for Someone You Love? Start Here

Spouses, adult children, and POA holders can begin the review — see what qualifies and what to gather.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Matthew T. Marin & Stefanie A. Murphy

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

If your husband, wife, or partner was recently diagnosed with NAION after taking Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound, you do not need their permission to find out what the litigation is and whether it applies to them. Marin & Murphy is currently accepting Ozempic (GLP-1) NAION cases, and a spouse can start the conversation.

You are probably reading this a few days or a few weeks after an appointment where someone used a word you had never heard before. Non-arteritic anterior ischemic optic neuropathy. NAION. They may have told you both that there is no known cause and that nothing can be done for the eye. That is a hard thing to be handed and then sent home with.

Here is what we can tell you plainly. The first part is true — for the eye itself, current medical guidance offers no treatment that restores what was lost. The second part — that no one knows why — is where the picture has changed. Since 2024, researchers and drug regulators outside the United States have been examining whether semaglutide medications are associated with NAION, and several have concluded that they are. That is why lawsuits exist, and why a law firm can be a useful phone call even though a doctor could not fix the eye.

216 cases
MDL 3163 (NAION), Sep 2026
4,022 cases
MDL 3094 (stomach injuries), Sep 2026
0 settlements
no case has resolved

Free, confidential case review. Marin & Murphy is currently accepting Ozempic (GLP-1) NAION vision-loss and stomach-injury cases. No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Start a free case review or call (888) 348-2735 — answered 24/7. You can call on his or her behalf.

⚖️

See if you qualify

A few quick questions about which GLP-1 medication you took, your diagnosis and testing, and your treatment. This is the initial intake screening, not a full case review. Most people finish in about two minutes.

  • 🔒 Confidential
  • No obligation
  • ⏱ ~2 minutes

Get started

Marin & Murphy Law Firm · Free & confidential · Stop messages anytime

You are allowed to be the one doing this

Spouses and partners are, in our experience and in the research on family caregivers, very often the person doing the reading. Pew Research found that two-thirds of online caregivers say their most recent health search was for someone else rather than for themselves. In the news coverage of GLP-1 vision-loss cases, it is repeatedly the wife or the husband who first says out loud: nothing else in your life changed except that medication.

There are practical reasons for this, too. A person who has just lost vision in one eye is often not comfortable reading long pages on a screen, is dealing with appointments and driving restrictions, and is exhausted. Someone reading on their behalf is not overstepping. It is how this actually gets done.

He has not asked you to do this. You can do it anyway, and then bring him what you found.

What the litigation is, in one paragraph

Federal NAION lawsuits against the makers of these medications are consolidated in MDL 3163, in the U.S. District Court for the Eastern District of Pennsylvania, before Judge Karen S. Marston. As of the September 2026 report from the Judicial Panel on Multidistrict Litigation, 216 cases were pending there. A separate federal proceeding, MDL 3094, handles stomach injuries and had 4,022 cases pending.

New Jersey has also designated state-court Multicounty Litigations for both injury types. Nothing has been decided in any of them: no verdicts, no settlements, no trial dates. The claims are against the manufacturers — Novo Nordisk and Eli Lilly — over what the warning labels did and did not say.

What is different outside the United States

In June 2025, the European Medicines Agency’s safety committee concluded that NAION is a “very rare” side effect of semaglutide medicines, affecting up to 1 in 10,000 people taking them, and recommended that European product information be updated to list it. Regulators in the United Kingdom and Australia have moved in the same direction. As of August 7, 2026, the U.S. label for these medications has not been changed to add NAION. That divergence is a documented fact about labeling, not a finding by any court that the medication caused any individual’s injury.

Not your doctor, and not his fault

Two worries come up almost every time a spouse calls. The first: am I suing our doctor? No. These are claims against the drug manufacturers over the label. Your prescriber acted on what the label said. In many of these cases the prescriber’s records are the most useful evidence a claim has, and the diagnosing eye specialist is a witness, not a target.

The second worry is unspoken more often than it is said: that taking the medication was somehow a choice that invites blame. Why he was prescribed it is not what these cases are about. What the label said, and what it did not say, is what these cases are about.

What actually matters for eligibility

  • Brand-name medication. Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound — not generic or compounded versions.
  • An actual NAION diagnosis from a doctor, not a suspicion, and not simply blurred vision.
  • Diagnosed while taking the medication or after stopping it.
  • Some degree of permanent vision impairment.
  • Not sure whether what you have on paper meets these? Tell us anyway. Near-miss situations are worth the conversation, and we will tell you honestly if a claim would not move forward.

What to have ready before you call

You do not need any of this to make the call, and nobody will quiz you. But if you have it, the conversation goes faster: the names of the medications and whether they were brand-name; roughly when he started and stopped; the prescribing doctor and pharmacy; the eye doctor who made the NAION diagnosis and the month and year; and whether there was an emergency-room visit. Our caregiver checklist lists everything, including what to stop throwing away.

Free, confidential case review. Marin & Murphy is currently accepting Ozempic (GLP-1) NAION vision-loss cases. No fee unless there is a recovery. Marin & Murphy is licensed in Rhode Island, Connecticut, Massachusetts, and South Carolina; matters elsewhere may be referred to lawyers licensed in your state.

Start a free case review or call (888) 348-2735. If you are calling for your spouse, say so — we will take it from there.

Common questions

Can I start a claim for my husband or wife?

You can start the conversation, gather the records, and give us the facts. The injured person themselves generally has to be the one who decides to bring a claim and signs the agreement, unless they have legally appointed someone to act for them. Many claims begin exactly this way — with a spouse calling first.

Do I need power of attorney to call about my spouse’s injury?

No. Power of attorney is not required to ask questions, learn about the litigation, or find out whether the criteria fit. It matters later, if the injured person needs someone else to sign on their behalf. Our power of attorney page explains what it does and does not allow.

Are we suing our doctor?

No. These lawsuits are against the drug manufacturers — Novo Nordisk and Eli Lilly — not against your prescribing doctor, your eye specialist, or your pharmacy. The prescriber’s records usually help the claim.

Has any GLP-1 vision-loss case been settled?

No. As of September 2026 there are no settlements and no verdicts in any GLP-1 injury lawsuit, and no trial date has been set in either federal proceeding. Anyone quoting a settlement amount is speculating.

Sources
  • JPML MDL statistics report, September 2026 (MDL 3094; MDL 3163)
  • JPML Transfer Order, MDL No. 3163 (Dec. 15, 2025)
  • European Medicines Agency, PRAC conclusion on NAION and semaglutide medicines (June 6, 2025)
  • Hathaway JT, et al., JAMA Ophthalmology (July 3, 2024), doi:10.1001/jamaophthalmol.2024.2296
  • Pew Research Center, “Family Caregivers Online” (2012)

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone’s injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber.

Attorney Advertising.

This page is attorney advertising and is for informational purposes only; it is not legal or medical advice. Prior results do not guarantee a similar outcome. Contacting the firm does not create an attorney-client relationship.

For families & caregivers: the caregiver checklist, calling for a parent, wrongful-death claims, and power of attorney.